Status | |||
---|---|---|---|
Control | Subclinical | Clinical | |
CCR9 | 23.23 ± 1.34 | 20.98 ± 1.31 | 140.15 ± 1.31 |
Pr(> t) | 1.89E−44 | 2.27E−49 | 4.12E−89 |
CD4 | 585.79 ± 1.23 | 585.21 ± 1.21 | 424.80 ± 1.21 |
Pr(> t) | 6.39E−119 | 2.05E−129 | 3.11E−125 |
CD8α | 810.48 ± 1.21 | 842.23 ± 1.19 | 514.45 ± 1.19 |
Pr(> t) | 1.71E−127 | 5.36E−140 | 8.33E−132 |
CXCR3 | 116.29 ± 14.81 | 177.98 ± 14.21 | 1538.85 ± 13.66 |
Pr(> t) | 4.99E−16 | 3.42E−27 | 3.77E−76 |
FoxP3 | 1111.78 ± 1.11 | 711.20 ± 1.10 | 520.61 ± 1.10 |
Pr(> t) | 6.61E−177 | 4.21E−182 | 1.45E−176 |
TcR1-N24 | 1194.59 ± 1.15 | 1222.86 ± 1.13 | 506.25 ± 1.13 |
Pr(> t) | 2.10E−150 | 3.91E−163 | 1.87E−148 |